Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.55 |
| ▸ | PPARG | P37231 | 3/20 | 0.55 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.55 |
| ▸ | RXRA | P19793 | 2/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | F7 | P08709 | 3/20 | 0.52 |
| ▸ | F3 | P13726 | 3/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14767921 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL14767922 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL892782 | 0.95 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL892781 | 0.95 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL5774607 | 0.94 | GABRR1 (0.46) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL5586095 | 0.94 | GABRR1 (0.46) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL5586091 | 0.94 | GABRR1 (0.46) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL29619483 | 0.89 | ALDH1A1 (0.58) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL3224652 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP19A1PPARGOXER1 | |
| SCHEMBL20553456 | 0.86 | ALDH1A1 (0.60) | ALDH1A1MAPTCYP19A1PPARGOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2010508259-A | — | — | 2010-03-18 | — | — | JP | claimed |
| US-20100035990-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-02-11 | — | — | US | claimed |
| EP-2094640-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | Pronova BioPharma Norge AS (NO) | 2009-09-02 | — | — | EP | claimed |
| WO-2008053331-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | PRONOVA BIOPHARMA NORGE A/S (SE) | 2008-05-08 | — | — | WO | claimed |
| EP-3383380-B1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2023-01-04 | — | — | EP | disclosed |
| US-8399516-B2 | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) | PRONOVA BIOPHARMA NORGE AS (NO) | 2013-03-19 | — | — | US | disclosed |
| US-20120065260-A1 | NOVEL COMPOUNDS | Pronova BioPhrma Norge AS | 2012-03-15 | — | — | US | disclosed |
| US-8034842-B2 | Compounds | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-10-11 | — | — | US | disclosed |
| US-20100267828-A1 | DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-10-21 | — | — | US | disclosed |
| US-20100035990-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-02-11 | — | — | US | disclosed |
| EP-2094640-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | Pronova BioPharma Norge AS (NO) | 2009-09-02 | — | — | EP | disclosed |
| US-20090203778-A1 | FATTY ACID ANALOGUES, I.E. INCLUDING DHA DERIVATIVES FOR USES AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2009-08-13 | — | — | US | disclosed |
| US-7550613-B2 | alpha-methoxy docosahexanoic acid ethyl ester, alpha-iodo-docosahexanoic acid ethyl ester; antidiabetic for diabetes type 2, cardiovascular disorders, obesity, amyloidosis, prophylaxis; free of 4,7,10,13,16,19-docosahexanoic acid ( DHA), alpha-methyl DHA, alpha-methyl DHA-methyl ester | PRONOVA BIOPHARMA NORGE AS (NO) | 2009-06-23 | — | — | US | disclosed |
| US-20080300306-A1 | Novel Compounds | BRYHN MORTEN | 2008-12-04 | — | — | US | disclosed |
| WO-2008053340-A1 | A COMBINATION PRODUCT COMPRISING AT LEAST ONE LIPID SUBSTITUTED IN THE ALPHA POSITION AND AT LEAST ONE HYPOGLYCEMIC AGENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008053331-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR). | PRONOVA BIOPHARMA NORGE A/S (SE) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035990-A1 | ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR) | PPARG, PPARA, FFAR3 | ALDH1A1 1088/4885MAPT 4860/4885CYP19A1 922/4885 |
| US-20090203778-A1 | FATTY ACID ANALOGUES, I.E. INCLUDING DHA DERIVATIVES FOR USES AS A MEDICAMENT | ALOX12, ALOX15, ALOX5 | ALDH1A1 611/4885MAPT 933/4885CYP19A1 812/4885 |
| US-20100267828-A1 | DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | LIPA, LPL, PNLIP | ALDH1A1 1114/4885MAPT 4554/4885CYP19A1 1358/4885 |
| US-20080300306-A1 | Novel Compounds | GPR119, FFAR2, ALOX12 | ALDH1A1 868/4885MAPT 4615/4885CYP19A1 879/4885 |
| US-20120065260-A1 | NOVEL COMPOUNDS | FFAR2, GPR119, ALOX12 | ALDH1A1 911/4885MAPT 4633/4885CYP19A1 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.